Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elizabeth Apgar"'
Autor:
Mark J. Cziraky, Scott Abbott, Matt Nguyen, Kay Larholt, Elizabeth Apgar, Thomas Wasser, Poul Strange, Leon Shi, H. Courtenay Harrison, Beverly Everitt, Lynn Nowak
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 6, Iss 2 (2019)
**Background:** Many patients with type 2 diabetes mellitus (T2DM) do not have adequate glycemic control, leading to poor patient outcomes and high healthcare costs. **Objective:** This prospective pragmatic clinical trial evaluated V-Go, a wearable
Externí odkaz:
https://doaj.org/article/89733cc7314a40b3b3e424271cbbcd12
Autor:
H. Courtenay Harrison, Leon Shi, Mark J. Cziraky, Matt Nguyen, Scott D Abbott, T. Wasser, Lynn Nowak, Beverly Everitt, Elizabeth Apgar, Kay Larholt, Poul Strange
Publikováno v:
Journal of Health Economics and Outcomes Research
Background: Many patients with type 2 diabetes mellitus (T2DM) do not have adequate glycemic control, leading to poor patient outcomes and high healthcare costs. Objective: This prospective pragmatic clinical trial evaluated V-Go, a wearable insulin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff2d070be307ce01ef7b4d58ec1bf2c
https://doi.org/10.36469/9731
https://doi.org/10.36469/9731
Autor:
Lorie Ellis, Tanya Burton, Chris L. Pashos, Mekre Senbetta, R. Scott McKenzie, Elizabeth Apgar, Kay Larholt
Publikováno v:
Blood. 114:2482-2482
Abstract 2482 Poster Board II-459 Background: National coverage limitations for ESA treatment in cancer patients with CIA were established by the Centers for Medicare & Medicaid Services in July 2007. Clinical outcomes based on ESA dosing described i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0169a7153d0292d358296954eae205d2
https://doi.org/10.1182/blood.v114.22.2482.2482
https://doi.org/10.1182/blood.v114.22.2482.2482
Autor:
R. Scott McKenzie, Mitra Corral, Brahim Bookhart, Catherine Tak Piech, Elizabeth Apgar, Kay Larholt, Chris L. Pashos, Tanya Burton
Publikováno v:
Blood. 112:1301-1301
Background: In July 2007, the Centers for Medicare and Medicaid Services issued ESA coverage limitations for cancer patients with CIA through a national coverage determination (NCD). Clinical outcomes based on ESA dosing described in the NCD have not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5331e9dce9b40f463e17aaed206212be
https://doi.org/10.1182/blood.v112.11.1301.1301
https://doi.org/10.1182/blood.v112.11.1301.1301
Autor:
Tanya Burton, David C. Hoaglin, Catherine Tak Piech, Chris L. Pashos, Brahim Bookhart, Kay Larholt, Mitra Corral, R. Scott McKenzie, Elizabeth Apgar
Publikováno v:
Blood. 112:1304-1304
Background: Clinical trial evidence has demonstrated greater anemia-related fatigue at lower hemoglobin (Hb) levels in ESA-treated patients with chemotherapy-induced anemia (CIA). To understand these patient-reported outcomes (PROs), during ESA treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::255a8e5e2447098082305404bd97dc87
https://doi.org/10.1182/blood.v112.11.1304.1304
https://doi.org/10.1182/blood.v112.11.1304.1304
Autor:
Triano, Elizabeth Apgar
Publikováno v:
Christian Century. 3/23/2010, Vol. 127 Issue 6, p6-6. 1/3p.